This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Pevion Biotech (vaccines for infectious diseases and cancer) raised CHF35mm ($29.3mm) through its Series A financing led by first-time backer BZ Bank Aktiengesellschaft. Other new investors BB Biotech Ventures and CC Private Equity Partners were joined by returning shareholder Bachem Holding AG. The company will use the proceeds to move its Phase I hepatitis C and breast cancer vaccines into Phase II trials, and to advance its preclinical RSV and Candida vaccines into human studies.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?